These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12952762)

  • 1. Nail toxicity related to taxanes.
    Mourad YA; Matta-Muallem M; Shamseddine A
    Dermatol Online J; 2003 Aug; 9(3):15. PubMed ID: 12952762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Taxane-induced ungual anomalies].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 2000 Jan; 127(1):130. PubMed ID: 10717580
    [No Abstract]   [Full Text] [Related]  

  • 3. Docetaxel chemotherapy induces transverse superficial loss of the nail plate.
    Llombart-Cussac A; Pivot X; Spielmann M
    Arch Dermatol; 1997 Nov; 133(11):1466-7. PubMed ID: 9371043
    [No Abstract]   [Full Text] [Related]  

  • 4. Nail toxicity associated with paclitaxel treatment for ovarian cancer.
    Swenson KK; Bell EM; Nissen J
    Oncol Nurs Forum; 2013 Jan; 40(1):17-9. PubMed ID: 23269765
    [No Abstract]   [Full Text] [Related]  

  • 5. Docetaxel-related skin, nail, and vascular toxicity.
    Leonard GD; Zujewski JA
    Ann Pharmacother; 2003 Jan; 37(1):148. PubMed ID: 12564432
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical picture: nail changes secondary to docetaxel.
    Wasner G; Hilpert F; Baron R; Pfisterer J
    Lancet; 2001 Mar; 357(9260):910. PubMed ID: 11289346
    [No Abstract]   [Full Text] [Related]  

  • 7. Nail changes due to docetaxel.
    Pavithran K; Doval DC
    Br J Dermatol; 2002 Apr; 146(4):709-10. PubMed ID: 11966714
    [No Abstract]   [Full Text] [Related]  

  • 8. Taxane-induced nail changes: incidence, clinical presentation and outcome.
    Minisini AM; Tosti A; Sobrero AF; Mansutti M; Piraccini BM; Sacco C; Puglisi F
    Ann Oncol; 2003 Feb; 14(2):333-7. PubMed ID: 12562663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Yellow nails].
    Auvinet M; Dahan S; Dingremont C; Ollier S; Juchet H; Arlet P
    Rev Med Interne; 1998 May; 19(5):353-4. PubMed ID: 9775172
    [No Abstract]   [Full Text] [Related]  

  • 10. Nail changes secondary to docetaxel (Taxotere).
    Correia O; Azevedo C; Pinto Ferreira E; Braga Cruz F; Polónia J
    Dermatology; 1999; 198(3):288-90. PubMed ID: 10393455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel-induced subungual hemorrhage.
    Vanhooteghem O; André J; Vindevoghel A; Vandenbossche L; Vandeveire A; Song M
    Dermatology; 1997; 194(4):419-20. PubMed ID: 9252781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onycholysis in patients treated with docetaxel.
    Obermair A; Binder M; Barrada M; Bancher-Todesca D; Asseryanis E; Kubista E
    Ann Oncol; 1998 Feb; 9(2):230-1. PubMed ID: 9553674
    [No Abstract]   [Full Text] [Related]  

  • 13. Taxane-induced nail changes: Predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity.
    Can G; Aydiner A; Cavdar I
    Eur J Oncol Nurs; 2012 Jul; 16(3):270-5. PubMed ID: 21784705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nail bed dyschromia secondary to docetaxel therapy.
    Jacob CI; Patten SF
    Arch Dermatol; 1998 Sep; 134(9):1167-8. PubMed ID: 9762045
    [No Abstract]   [Full Text] [Related]  

  • 15. Images in clinical medicine. Nail changes after chemotherapy.
    Slee PH
    N Engl J Med; 1997 Jul; 337(3):168. PubMed ID: 9219703
    [No Abstract]   [Full Text] [Related]  

  • 16. Docetaxel-induced nail dystrophy.
    Nicolopoulos J; Howard A
    Australas J Dermatol; 2002 Nov; 43(4):293-6. PubMed ID: 12423438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is weekly docetaxel an active and gentle chemotherapy in the treatment of metastatic breast cancer?
    Maisano R; Mare M; Zavettieri M; Caristi N; Mesiti M; Scisca C; La Torre F
    Anticancer Res; 2003; 23(2C):1923-6. PubMed ID: 12820480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nail alterations secondary to pactitaxel [corrected] therapy.
    Almagro M; Pozo JD; Garcia J; Vasquez A; Fonseca E
    Eur J Dermatol; 2000 Mar; 10(2):146-7. PubMed ID: 10694317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onycholysis associated with weekly administration of paclitaxel.
    Flory SM; Solimando DA; Webster GF; Dunton CJ; Neufeld JM; Haffey MB
    Ann Pharmacother; 1999 May; 33(5):584-6. PubMed ID: 10369623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subungual abscess: a new ungual side-effect related to docetaxel therapy.
    Vanhooteghem O; Richert B; Vindevoghel A; Vandenbossche L; Vandeveire A; de la Brassinne M
    Br J Dermatol; 2000 Aug; 143(2):462-4. PubMed ID: 10951175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.